Discover top-quality products tailored for scientific and medical research. Request a personalized quote today
to enhance your projects.
Species | Human |
Cat.No | ABC-TC5537 |
Product Category | Primary Cells |
Size/Quantity | 1 vial |
Cell Type | Fibroblast |
Shipping Info | Dry ice |
Growth Conditions | 37 ℃, 5% CO2 |
Source Organ | Colorectal |
Disease | Colorectal Tumor Carcinoma |
Storage | Liquid Nitrogen |
Product Type | Human Primary Carcinoma Associated Fibroblasts |
Derived from human colon tumor tissue, Human Colorectal Tumor Carcinoma Associated Fibroblasts (CAFs) exhibit heightened cross-presentation proficiency. Notably, these CAFs showcase the presence of lysosomal protease cathepsin S within human colorectal cancer tissue. Through the cathepsin S-dependent vacuolar pathway, these CAFs proficiently cross-present antigens to cytotoxic CD8+ T cells, leading to a dampened cytotoxic T cell response. Functioning as pivotal components within the tumor microenvironment, CAFs wield substantial influence over tumor growth and metastasis dynamics. While research underscores CAFs’ potential to intensify malignant tumor aggressiveness, contrasting findings highlight their capability to restrain cancer progression.
Why choose Human Colorectal Tumor Carcinoma Associated Fibroblasts from AcceGen?
When considering your cell sourcing, AcceGen stands out as the preferred choice for Human Colorectal Tumor Carcinoma Associated Fibroblasts due to their superior quality and handling. These cells, cryo-preserved at passage 1, ensure viability with a minimum of 1,000,000 cells per vial. With the potential for 3-5 passages of expansion, they provide robust resources for your research needs.
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID).
FOR RESEARCH USE ONLY
Leveraging our Human Colorectal Tumor Carcinoma Associated Fibroblasts (CAFs), researchers established a 3D interpenetrating network hydrogel culture system. This innovative platform facilitated modulation of the tumor microenvironment’s mechanical attributes, enabling an in-depth exploration of CAF phenotype transitions and interactions with colorectal cancer cells. Manipulating mechanical properties revealed conditions correlating with patient survival or decline, offering novel insights with potential implications for future cancer therapies.